Your prediction
BiondVax Pharmaceuticals Ltd ADR Stock
BiondVax Pharmaceuticals Ltd ADR dominated the market today, gaining €0.050 (4.420%).
Our community identified positive and negative aspects for BiondVax Pharmaceuticals Ltd ADR stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the BiondVax Pharmaceuticals Ltd ADR stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of BiondVax Pharmaceuticals Ltd ADR in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of BiondVax Pharmaceuticals Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| BiondVax Pharmaceuticals Ltd ADR | 4.420% | -2.586% | -2.586% | -54.435% | -47.196% | - | - |
| X T L Biopharmaceuticals Ltd ADR | -0.690% | 5.926% | -8.333% | -55.864% | -40.417% | -16.374% | -47.057% |
| Palatin Technologies | 3.280% | -2.106% | -21.898% | -49.234% | -44.152% | -73.658% | -30.079% |
| Isoray Inc. | 10.470% | 10.219% | 9.713% | -57.809% | -14.613% | -28.454% | -46.374% |
